Related references
Note: Only part of the references are listed.Prognostic influence of hepatic margin after resection of colorectal liver metastasis: role of modern preoperative chemotherapy
Frank Makowiec et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2018)
Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-Analysis
Dimitrios Moris et al.
WORLD JOURNAL OF SURGERY (2018)
Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases
G. A. Margonis et al.
BRITISH JOURNAL OF SURGERY (2018)
Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival
Marco Calandri et al.
EUROPEAN RADIOLOGY (2018)
Technology of irreversible electroporation and review of its clinical data on liver cancers
Emil I. Cohen et al.
EXPERT REVIEW OF MEDICAL DEVICES (2018)
Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial
Robbert S. Puijk et al.
BMC CANCER (2018)
First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD)
Alfredo Carrato et al.
EUROPEAN JOURNAL OF CANCER (2017)
The role of image-guided therapy in the management of colorectal cancer metastatic disease
Thierry de Baere et al.
EUROPEAN JOURNAL OF CANCER (2017)
Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastases
Enrique Aranda et al.
FUTURE ONCOLOGY (2017)
Local Control Outcomes Using Stereotactic Body Radiation Therapy for Liver Metastases From Colorectal Cancer
Ji Hyeon Joo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
Theo Ruers et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials
Harpreet S. Wasan et al.
LANCET ONCOLOGY (2017)
Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins
Martina Distelmaier et al.
RADIOLOGY (2017)
Hepatic intra-arterial injection of irinotecan drug eluting beads (DEBIRI) for patients with unresectable colorectal liver metastases: A systematic review
Olaguoke Akinwande et al.
SURGICAL ONCOLOGY-OXFORD (2017)
Feasibility, safety and efficacy of two-stage hepatectomy for bilobar liver metastases of colorectal cancer: a LiverMetSurvey analysis
Jean Marc Regimbeau et al.
HPB (2017)
ALPPS as a salvage procedure after insufficient future liver remnant hypertrophy following portal vein occlusion
Marcelo Enne et al.
HPB (2017)
Percutaneous Irreversible Electroporation: Long-term survival analysis of 71 patients with inoperable malignant hepatic tumors
C. Niessen et al.
SCIENTIFIC REPORTS (2017)
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
Theo Ruers et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC).
Alan P. Venook et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Treatment Options in Oligometastatic Disease: Stereotactic Body Radiation Therapy - Focus on Colorectal Cancer
Aaron T. Wild et al.
VISCERAL MEDICINE (2017)
REsect: Blinded assessment of amenability to potentially curative treatment of previously unresectable colorectal cancer liver metastases (CRC LM) after chemotherapy +/- RadioEmbolization (SIRT) in the randomized SIRFLOX trial.
Benjamin Garlipp et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Image guided SBRT for multiple liver metastases with ExacTrac® Adaptive Gating
Carmen Rubio et al.
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY (2017)
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials
D. Arnold et al.
ANNALS OF ONCOLOGY (2017)
Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases
Neal Bhutiani et al.
WORLD JOURNAL OF SURGERY (2016)
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2016)
Outcome after associating liver partition and portal vein ligation for staged hepatectomy and conventional two-stage hepatectomy for colorectal liver metastases
R. Adam et al.
BRITISH JOURNAL OF SURGERY (2016)
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer
Guy A. van Hazel et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases
Andor F. van den Hoven et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes-A 10-year Experience at a Single Center
Waleed Shady et al.
RADIOLOGY (2016)
A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90
Jin-Yao Teo et al.
HPB (2016)
Parenchymal-sparing hepatectomies (PSH) for bilobar colorectal liver metastases are associated with a lower morbidity and similar oncological results: a propensity score matching analysis
Riccardo Memeo et al.
HPB (2016)
Percutaneous cryoablation of hepatic tumors: long-term experience of a large US series
Peter J. Littrup et al.
ABDOMINAL RADIOLOGY (2016)
Long-term safety and efficacy of stereotactic body radiation therapy for hepatic oligometastases
Benjamin D. Goodman et al.
PRACTICAL RADIATION ONCOLOGY (2016)
Role of imaging for patients with colorectal hepatic metastases: what the radiologist needs to know
Michael J. Reiter et al.
ABDOMINAL IMAGING (2015)
Chemotherapy for Patients with Colorectal Liver Metastases Who Underwent Curative Resection Improves Long-Term Outcomes: Systematic Review and Meta-analysis
Raphael L. C. Araujo et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Randomized Controlled Trial of Irinotecan Drug-Eluting Beads With Simultaneous FOLFOX and Bevacizumab for Patients With Unresectable Colorectal Liver-Limited Metastasis
Robert C. G. Martin et al.
CANCER (2015)
Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus
Rene Adam et al.
CANCER TREATMENT REVIEWS (2015)
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis
Filippo Pietrantonio et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the interventional oncology sans frontiSres meeting 2013
Alice Gillams et al.
EUROPEAN RADIOLOGY (2015)
A review of conventional and drug-eluting chemoembolization in the treatment of colorectal liver metastases: principles and proof
David M. Liu et al.
FUTURE ONCOLOGY (2015)
Stereotactic radiation therapy for liver metastases: factors affecting local control and survival
Nicolaus H. J. Andratschke et al.
RADIATION ONCOLOGY (2015)
Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial
T. Gruenberger et al.
ANNALS OF ONCOLOGY (2015)
Diagnostic accuracy and impact on management of F-18-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review
Anna Margherita Maffione et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer
Marta Scorsetti et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Complex Surgical Strategies to Improve Resectability in Borderline-Resectable Disease
Motaz Qadan et al.
CURRENT COLORECTAL CANCER REPORTS (2015)
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer
J. Y. Douillard et al.
ANNALS OF ONCOLOGY (2014)
Seeing the forest through the trees: A systematic review of the safety and efficacy of combination chemotherapies used in the treatment of metastatic colorectal cancer
Tanios Bekaii-Saab et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
Clinically Useful Diagnostic Tool of Contrast Enhanced Ultrasonography for Focal Liver Masses: Comparison to Computed Tomography and Magnetic Resonance Imaging
Sung Woo Ryu et al.
GUT AND LIVER (2014)
Left-Liver Hypertrophy After Therapeutic Right-Liver Radioembolization Is Substantial but Less Than After Portal Vein Embolization
Benjamin Garlipp et al.
HEPATOLOGY (2014)
Effect of PET Before Liver Resection on Surgical Management for Colorectal Adenocarcinoma Metastases A Randomized Clinical Trial
Carol-Anne Moulton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
Volker Heinemann et al.
LANCET ONCOLOGY (2014)
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial
John Primrose et al.
LANCET ONCOLOGY (2014)
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
Fotios Loupakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effect of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases
Dexiang Zhu et al.
PLOS ONE (2014)
Margin Status Remains an Important Determinant of Survival After Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy
Andreas Andreou et al.
ANNALS OF SURGERY (2013)
Portal Vein Embolization Before Liver Resection: A Systematic Review
K. P. van Lienden et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2013)
Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation
M. Scharitzer et al.
EUROPEAN RADIOLOGY (2013)
Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis
Yu-Yu Lu et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2013)
Predictive and prognostic roles of BRAF mutation in patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: A meta-analysis
Qi Xu et al.
JOURNAL OF DIGESTIVE DISEASES (2013)
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
Bernard Nordlinger et al.
LANCET ONCOLOGY (2013)
Cryotherapy for liver metastases
Malgorzata M. Bala et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Integrating Radioembolization With Chemotherapy in the Treatment Paradigm for Unresectable Colorectal Liver Metastases
Harpreet Wasan et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2012)
Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy
A. Hendlisz et al.
ANNALS OF ONCOLOGY (2012)
Right Portal Vein Ligation Combined With In Situ Splitting Induces Rapid Left Lateral Liver Lobe Hypertrophy Enabling 2-Staged Extended Right Hepatic Resection in Small-for-Size Settings
Andreas A. Schnitzbauer et al.
ANNALS OF SURGERY (2012)
Irinotecan Loaded in Eluting Beads: Preclinical Assessment in a Rabbit VX2 Liver Tumor Model
Pramod P. Rao et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2012)
The Oncosurgery Approach to Managing Liver Metastases from Colorectal Cancer: A Multidisciplinary International Consensus
Rene Adam et al.
ONCOLOGIST (2012)
Radiofrequency ablation in the treatment of liver metastases from colorectal cancer
Roberto Cirocchi et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection
R. Wong et al.
ANNALS OF ONCOLOGY (2011)
Outcome After Laparoscopic Radiofrequency Ablation of Technically Resectable Colorectal Liver Metastases
Chet W. Hammill et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Stereotactic Body Radiotherapy for Colorectal Liver Metastases A Pooled Analysis
Daniel T. Chang et al.
CANCER (2011)
Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A standard definition of major hepatectomy: resection of four or more liver segments
Srinevas K. Reddy et al.
HPB (2011)
High-Intensity Focused Ultrasound Ablation: Effective and Safe Therapy for Solid Tumors in Difficult Locations
Franco Orsi et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial
C. Garufi et al.
BRITISH JOURNAL OF CANCER (2010)
Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases
M. Cosimelli et al.
BRITISH JOURNAL OF CANCER (2010)
Quality Improvement Guidelines for Radiofrequency Ablation of Liver Tumours
Laura Crocetti et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy
Alain Hendlisz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
Gunnar Folprecht et al.
LANCET ONCOLOGY (2010)
Association of Computed Tomography Morphologic Criteria With Pathologic Response and Survival in Patients Treated With Bevacizumab for Colorectal Liver Metastases
Yun Shin Chun et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases
Kyle E. Rusthoven et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
Carsten Bokemeyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Long-Term Results of Two-Stage Hepatectomy for Irresectable Colorectal Cancer Liver Metastases
Dennis A. Wicherts et al.
ANNALS OF SURGERY (2008)
Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome - Trends in treatment over time in 440 patients
Jason S. Gold et al.
ANNALS OF SURGERY (2008)
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer:: A randomized phase III study
Leonard B. Saltz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
Bernard Nordlinger et al.
LANCET (2008)
Surgical therapy for colorectal metastases to the liver
Timothy M. Pawlik et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2007)
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer:: The Gruppo Oncologico Nord Ovest
Alfredo Falcone et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Preoperative positron emission tomography to evaluate potentially resectable hepatic colorectal metastases
David L. Joyce et al.
ARCHIVES OF SURGERY (2006)
Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study
Alejandra Mendez Romero et al.
ACTA ONCOLOGICA (2006)
A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer
J Leporrier et al.
BRITISH JOURNAL OF SURGERY (2006)
Neoadjuvant treatment of unresectable colorectal liver metastases:: correlation between tumour response and resection rates
G Folprecht et al.
ANNALS OF ONCOLOGY (2005)
Tumor progression while on chemotherapy - A contraindication to liver resection for multiple colorectal metastases?
R Adam et al.
ANNALS OF SURGERY (2004)
Tumor ablation with radio-frequency energy
GS Gazelle et al.
RADIOLOGY (2000)
Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors
R Adam et al.
ANNALS OF SURGERY (2000)
Share Paper
